News Alert

Fed. Court Rejects AstraZeneca’s Request to Halt Mississippi’s Contract Pharmacy Law, Dealing Another Blow to Drug Industry

A Mississippi federal court has denied AstraZeneca’s request for a preliminary injunction against that state's contract pharmacy access law.
A federal judge this week denied AstraZeneca’s request for a preliminary injunction against Mississippi’s contract pharmacy access law, marking the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Biogen to Extend 340B Contract Pharmacy Restrictions to Grantees and Add New Requirements for Hospitals, Novartis to Require Claims Submissions for Hospitals

Biogen is extending its contract pharmacy restrictions to non-hospital covered entities in January.
Biogen will soon extend its contract pharmacy restrictions to non-hospital covered entities, while Novartis will require hospitals to submit claims [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ruling Against West Virginia Contract Pharmacy Access Law May Increase Odds of Eventual SCOTUS Review as State Providers Vow to ‘Not Give Up’

A recent federal appeals court ruling against West Virginia's contract pharmacy access law may increase the chances that the U.S. Supreme Court eventually takes up the issue.
A federal judge’s recent ruling against West Virginia’s 340B contract pharmacy law advances the drug industry’s push to bring the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Action Year in Review: States Passed More 340B Contract Pharmacy Access Laws as Drugmakers Pursued Legal Challenges and Dark-Money Campaign Threatened GOP Lawmakers

Six states passed 340B contract pharmacy access bills in 2024, bringing the total to eight.
Contract pharmacy restrictions—and legislation to override them—dominated 340B policy discussions in statehouses and courtrooms across the country this year, as [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House GOP Names New Members to Key 340B Committee; Staffer with Drug Industry Ties To Serve in Top Post

The House Energy and Commerce Committee is adding 10 new GOP members and some new staffers in the 119th Congress.
The 119th Congress’ House Energy and Commerce (E&C) Committee—an influential panel with jurisdiction over the Medicaid and 340B programs—will feature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers Drop Lawsuits Against Kansas 340B Contract Pharmacy Law After AG Says Statute Does Not ‘Prohibit or Forbid Anything’

Kansas Attorney General Kris Kobach (R) said the state's 340B contract pharmacy access law "does not require anything of a drug manufacturer nor does it prohibit or forbid anything.”
Three manufacturers and a drug industry trade group dropped their lawsuits against Kansas’ 340B contract pharmacy access law after the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, Missouri

Key briefs were filed this week in litigation over state contract pharmacy access laws in Mississippi and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B Report [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Federal Judge Blocks West Virginia from Enforcing Contract Pharmacy Access Law While Challenges Play Out

U.S. District Judge Thomas E. Johnston of the Southern District of West Virginia granted motions for preliminary injunction against West Virginia’s contract pharmacy access law.

In the first major legal setback for states pursuing contract pharmacy protections, a federal district judge ruled yesterday that West Virginia officials cannot enforce the state’s contract pharmacy access law while three drug industry legal challenges play out.

U.S. District

Read More »

IRA Rollout, Regulatory Gaps May Drive Major 340B Reforms in 2025, Says Adam Fein of Drug Channels

Adam Fein, Ph.D, president of Drug Channels Institute, predicted the IRA's implementation could drive major 340B changes during a Dec. 13 webinar.
Emerging regulatory conflicts between the Inflation Reduction Act (IRA) and the 340B program may soon force policymakers to enact major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie’s Latest 340B Restrictions Appear to Target Hospital Alternative Distribution Models But May Not Be Enforceable, Experts Say

Experts said that AbbVie’s latest contract pharmacy policy change appears to target alternative distribution models.
AbbVie’s latest move to extend certain 340B contract pharmacy restrictions to federal grantees also appears to target hospitals’ use of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live